Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Or

Organon & Co

OGN · NYSE
OGN · NYSE

Next Earnings: 12 Aug 2025

9.46
USD-0.17-1.77%

Latest News

    coinpedia

    Origin Protocol Price Prediction 2025, 2026 – 2030: Is OGN A Good Investment?

      SeekingAlpha

      Organon to acquire Dermavant for $1.2 billion

        CryptoNewsZ

        OGN & OGV merger finalized, Enhancing blockchain unity

          CoinTurk News

          Significant Growth in Origin Protocol’s OGN Following Strategic Merge Announcement

            cryptonews

            Origin Protocol’s OGN and OGV Tokens Will Be Merged to Improve Ethereum Liquid Staking

              CoinOtag

              OGN Failed to Hold Above Critical Resistance! What’s Next? Current OGN Coin Analysis!

              Hold

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              9.40USD
              9.78USD

              52 Week Range

              8.01USD
              23.10USD

              Market Cap

              2.51BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NYSE

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US68622V1061

              CUSIP

              68622V106

              Sector

              Healthcare

              Industry

              Drug Manufacturers - General

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              3.28

              PEG Ratio

              -

              Book Value

              2.10

              Dividend Share

              1.12

              Dividend Yield

              0.83%

              Earnings Share

              2.88

              Wall Street Target Price

              14.00

              EPS Estimate Current Year

              3.86

              EPS Estimate Next Year

              4.08

              EPS Estimate Current Quarter

              0.8934

              EPS Estimate Next Quarter

              0.8965

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              6,294,000,128

              Gross Profit TTM

              3,599,000,064

              EBITDA

              1,695,000,064

              Profit Margin

              11.92%

              Return On Assets TTM

              6.98%

              Return On Equity TTM

              254.24%

              Revenue Per Share TTM

              24.434

              Qtly Revenue Growth YOY

              -6.70%

              Diluted Eps TTM

              2.88

              Qtly Earnings Growth YOY

              -57.70%

              Valuation

              Trailing PE

              3.28

              Forward PE

              5

              Price Sales TTM

              0.3907

              Price Book MRQ

              4.5372

              Enterprise Value Revenue

              1

              Enterprise Value EBITDA

              7

              Peers analysis

              • Roche Holding AG Participation
                RHHVFRoche Holding AG Participation

                324.56

                1.31%
              • Eli Lilly and Company
                LLYEli Lilly and Company

                771.50

                1.24%
              • Roche Holding Ltd ADR
                RHHBYRoche Holding Ltd ADR

                40.09

                0.53%
              • Johnson & Johnson
                JNJJohnson & Johnson

                163.70

                0.40%
              • Novartis AG ADR
                NVSNovartis AG ADR

                114.61

                0.18%
              • Novartis AG
                NVSEFNovartis AG

                118.70

                0.03%
              • AstraZeneca PLC
                AZNCFAstraZeneca PLC

                142.02

                0.00%
              • Roche Holding AG
                RHHBFRoche Holding AG

                337.60

                0.00%
              • Novo Nordisk A/S
                NONOFNovo Nordisk A/S

                64.58

                -1.31%
              • AbbVie Inc
                ABBVAbbVie Inc

                189.35

                -1.15%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is Organon & Co stock price today?

              What is Organon & Co stock ticker?

              Is OGN stock price going up?

              What is the analyst recommendation for OGN?

              What is OGN market cap?

              Does OGN release financial reports?

              When is OGN next earnings date?

              What were OGN Earnings for the last quarter?

              What was OGN Revenue for the last quarter?

              What was OGN Net Income for the last quarter?

              Does OGN pay dividends?

              How many employees does OGN have?

              What is OGN EBITDA?

              How to buy OGN stocks?

              Should I invest in OGN stock?